Protagonist Therapeutics PTGX Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's change in other assets?
- Protagonist Therapeutics (PTGX) reported change in other assets of $1.92M in Q1 2026.
- How has Protagonist Therapeutics's change in other assets changed year-over-year?
- Protagonist Therapeutics's change in other assets increased by 102.3% year-over-year, from $948K to $1.92M.
- What is the long-term trend for Protagonist Therapeutics's change in other assets?
- Over 3 years (2021 to 2025), Protagonist Therapeutics's change in other assets has grown at a -9.3% compound annual growth rate (CAGR), from $3.23M to $2.41M.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.